Colonoscopy Every Three Years Indicated For Those With Family History Of Polyps
Men With Low PSA Scores May Not Need Annual Tests, Data From PLCO Trial Suggests
Gleevec Better Than Interferon For Newly Diagnosed CML
Two-Drug Combination Extends Survival Of Mesothelioma
Preventive Surgery Cuts Risk Of Breast, Ovarian Cancers
Two-Month Survival Benefit For Some NSCLC Patients
Cancer Cases To Double By 2050, Annual Report Says
Women Radiated For Wilms’ At Risk For Complications In Pregnancy, Study Finds
St. John’s Wort Not Indicated For Patients On Irinotecan
Large Pregnancy Weight Gain Raises Risk For Breast Cancer
Clinical Trials Approved Last Month By NCI’s CTEP
Trending Stories
- Class action complaint alleging GRAIL insider fraud resubmitted after dismissal
- Cancer centers adapt to life without site visits as NIH changes CCSG review
- How GLP-1RA drugs are reshaping patient physiology and the future of oncology
- Jonathan Licht named president, chief scientific officer at Van Andel Institute
- Friends publishes three white papers ahead of annual meeting
Topics: Clinical trials on rare cancers, combination drug trials, multi-regional studies - Early endpoints are a balance of risk and benefit









